• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β(3)肾上腺素能刺激心脏 Na+-K+泵通过逆转抑制性氧化修饰。

β(3) adrenergic stimulation of the cardiac Na+-K+ pump by reversal of an inhibitory oxidative modification.

机构信息

North Shore Heart Research Group, Kolling Institute of Medical Research, University of Sydney, Australia.

出版信息

Circulation. 2010 Dec 21;122(25):2699-708. doi: 10.1161/CIRCULATIONAHA.110.964619. Epub 2010 Dec 6.

DOI:10.1161/CIRCULATIONAHA.110.964619
PMID:21135361
Abstract

BACKGROUND

inhibition of L-type Ca(2+) current contributes to negative inotropy of β(3) adrenergic receptor (β(3) AR) activation, but effects on other determinants of excitation-contraction coupling are not known. Of these, the Na(+)-K(+) pump is of particular interest because of adverse effects attributed to high cardiac myocyte Na(+) levels and upregulation of the β(3) AR in heart failure.

METHODS AND RESULTS

we voltage clamped rabbit ventricular myocytes and identified electrogenic Na(+)-K(+) pump current (I(p)) as the shift in holding current induced by ouabain. The synthetic β(3) AR agonists BRL37344 and CL316,243 and the natural agonist norepinephrine increased I(p). Pump stimulation was insensitive to the β(1)/β(2) AR antagonist nadolol and the protein kinase A inhibitor H-89 but sensitive to the β(3) AR antagonist L-748,337. Blockade of nitric oxide synthase abolished pump stimulation and an increase in fluorescence of myocytes loaded with a nitric oxide-sensitive dye. Exposure of myocytes to β(3) AR agonists decreased β(1) Na(+)-K(+) pump subunit glutathionylation, an oxidative modification that causes pump inhibition. The in vivo relevance of this was indicated by an increase in myocardial β(1) pump subunit glutathionylation with elimination of β(3) AR-mediated signaling in β(3) AR(-/-) mice. The in vivo effect of BRL37344 on contractility of the nonfailing and failing heart in sheep was consistent with a beneficial effect of Na(+)-K(+) pump stimulation in heart failure.

CONCLUSIONS

the β(3) AR mediates decreased β(1) subunit glutathionylation and Na(+)-K(+) pump stimulation in the heart. Upregulation of the receptor in heart failure may be a beneficial mechanism that facilitates the export of excess Na(+).

摘要

背景

L 型钙电流的抑制导致β(3)肾上腺素能受体(β(3)AR)激活的负性肌力作用,但对兴奋-收缩偶联的其他决定因素的影响尚不清楚。在这些因素中,钠-钾泵特别引人关注,因为高心肌细胞钠离子水平和心力衰竭时β(3)AR 的上调会产生不良影响。

方法和结果

我们对兔心室肌细胞进行电压钳位,并通过哇巴因诱导的保持电流变化来鉴定生电性钠-钾泵电流(I(p))。合成的β(3)AR 激动剂 BRL37344 和 CL316,243 以及天然激动剂去甲肾上腺素增加了 I(p)。泵刺激对β(1)/β(2)AR 拮抗剂纳多洛尔和蛋白激酶 A 抑制剂 H-89 不敏感,但对β(3)AR 拮抗剂 L-748,337 敏感。一氧化氮合酶阻断消除了泵刺激,并增加了用一氧化氮敏感染料负载的细胞的荧光。β(3)AR 激动剂暴露降低了β(1)钠-钾泵亚基的谷胱甘肽化,这是一种导致泵抑制的氧化修饰。β(3)AR(-/-)小鼠中消除β(3)AR 介导的信号转导导致心肌β(1)泵亚基谷胱甘肽化增加,表明这与体内的相关性。在绵羊中,BRL37344 对正常和衰竭心脏收缩性的体内作用与心力衰竭时钠-钾泵刺激的有益作用一致。

结论

β(3)AR 在心脏中介导β(1)亚基谷胱甘肽化减少和钠-钾泵刺激。心力衰竭时受体的上调可能是促进多余钠离子输出的有益机制。

相似文献

1
β(3) adrenergic stimulation of the cardiac Na+-K+ pump by reversal of an inhibitory oxidative modification.β(3)肾上腺素能刺激心脏 Na+-K+泵通过逆转抑制性氧化修饰。
Circulation. 2010 Dec 21;122(25):2699-708. doi: 10.1161/CIRCULATIONAHA.110.964619. Epub 2010 Dec 6.
2
Enhanced inhibition of L-type Ca2+ current by beta3-adrenergic stimulation in failing rat heart.β3 肾上腺素能刺激对衰竭大鼠心脏 L 型钙电流的增强抑制作用。
J Pharmacol Exp Ther. 2005 Dec;315(3):1203-11. doi: 10.1124/jpet.105.089672. Epub 2005 Aug 31.
3
Rabbit, a relevant model for the study of cardiac beta 3-adrenoceptors.兔子,一种用于研究心脏β3肾上腺素能受体的相关模型。
Exp Physiol. 2009 Apr;94(4):400-11. doi: 10.1113/expphysiol.2008.045179. Epub 2009 Jan 16.
4
β3-Adrenoceptor activation relieves oxidative inhibition of the cardiac Na+-K+ pump in hyperglycemia induced by insulin receptor blockade.β3肾上腺素能受体激活可减轻胰岛素受体阻断诱导的高血糖症中氧化对心脏钠钾泵的抑制作用。
Am J Physiol Cell Physiol. 2015 Sep 1;309(5):C286-95. doi: 10.1152/ajpcell.00071.2015. Epub 2015 Jun 10.
5
Protein kinase-dependent oxidative regulation of the cardiac Na+-K+ pump: evidence from in vivo and in vitro modulation of cell signalling.蛋白激酶依赖性的心脏钠钾泵的氧化调节:来自细胞信号转导的体内和体外调节的证据。
J Physiol. 2013 Jun 15;591(12):2999-3015. doi: 10.1113/jphysiol.2013.252817. Epub 2013 Apr 15.
6
Targeting Cardiac Myocyte Na-K Pump Function With β3 Adrenergic Agonist in Rabbit Model of Severe Congestive Heart Failure.β3 肾上腺素能激动剂靶向治疗兔严重充血性心力衰竭模型中心肌细胞钠钾泵功能。
Circ Heart Fail. 2020 Sep;13(9):e006753. doi: 10.1161/CIRCHEARTFAILURE.119.006753. Epub 2020 Aug 26.
7
The use of beta3-adrenergic receptor agonists in the treatment of heart failure.β3-肾上腺素能受体激动剂在心力衰竭治疗中的应用。
Curr Opin Investig Drugs. 2009 Sep;10(9):955-62.
8
Upregulation of functional beta(3)-adrenergic receptor in the failing canine myocardium.衰竭犬心肌中功能性β(3)-肾上腺素能受体的上调。
Circ Res. 2001 Sep 28;89(7):599-606. doi: 10.1161/hh1901.098042.
9
Beta3-adrenoceptor in the eel (Anguilla anguilla) heart: negative inotropy and NO-cGMP-dependent mechanism.鳗鱼(欧洲鳗鲡)心脏中的β3-肾上腺素能受体:负性肌力作用及一氧化氮-环鸟苷酸依赖性机制。
J Exp Biol. 2006 Dec;209(Pt 24):4966-73. doi: 10.1242/jeb.02595.
10
β-Adrenergic regulation of the cardiac Na+-K+ ATPase mediated by oxidative signaling.β-肾上腺素能通过氧化信号调节心脏 Na+-K+ATP 酶。
Trends Cardiovasc Med. 2012 May;22(4):83-7. doi: 10.1016/j.tcm.2012.06.017.

引用本文的文献

1
Regulation of β-Adrenergic Receptors in the Heart: A Review on Emerging Therapeutic Strategies for Heart Failure.β-肾上腺素受体在心脏中的调控:心力衰竭治疗新策略的综述。
Cells. 2024 Oct 10;13(20):1674. doi: 10.3390/cells13201674.
2
Roles of β-adrenoceptor Subtypes and Therapeutics in Human Cardiovascular Disease: Heart Failure, Tachyarrhythmias and Other Cardiovascular Disorders.β-肾上腺素受体亚型在人类心血管疾病中的作用及治疗:心力衰竭、心动过速性心律失常和其他心血管疾病。
Handb Exp Pharmacol. 2024;285:247-295. doi: 10.1007/164_2024_720.
3
β3 adrenergic agonism: A novel pathway which improves right ventricular-pulmonary arterial hemodynamics in pulmonary arterial hypertension.
β3 肾上腺素能激动剂:改善肺动脉高压患者右心室-肺动脉血液动力学的新途径。
Physiol Rep. 2023 Jan;11(1):e15549. doi: 10.14814/phy2.15549.
4
Endothelial cell dysfunction: Implications for the pathogenesis of peripheral artery disease.内皮细胞功能障碍:对周围动脉疾病发病机制的影响。
Front Cardiovasc Med. 2022 Nov 16;9:1054576. doi: 10.3389/fcvm.2022.1054576. eCollection 2022.
5
Protocol for the Stimulating β-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial disease.《β肾上腺素能受体刺激治疗外周动脉疾病(STAR-PAD)试验方案》:一项双盲、随机、安慰剂对照研究,评估米拉贝隆对外周动脉疾病患者功能表现的影响。
BMJ Open. 2021 Sep 28;11(9):e049858. doi: 10.1136/bmjopen-2021-049858.
6
Electrophysiological Remodeling: Cardiac T-Tubules and ß-Adrenoceptors.电生理重构:心脏 T 小管和β肾上腺素能受体。
Cells. 2021 Sep 17;10(9):2456. doi: 10.3390/cells10092456.
7
Therapeutic Challenges and Emerging Treatment Targets for Pulmonary Hypertension in Left Heart Disease.左心疾病相关肺动脉高压的治疗挑战和新兴治疗靶点。
J Am Heart Assoc. 2021 Jun;10(11):e020633. doi: 10.1161/JAHA.120.020633. Epub 2021 May 25.
8
Adrenergic Receptor Stimulation Promotes Reperfusion in Ischemic Limbs in a Murine Diabetic Model.肾上腺素能受体刺激促进小鼠糖尿病模型缺血肢体的再灌注
Front Pharmacol. 2021 Apr 22;12:666334. doi: 10.3389/fphar.2021.666334. eCollection 2021.
9
FXYD proteins and sodium pump regulatory mechanisms.FXYD 蛋白与钠泵调节机制。
J Gen Physiol. 2021 Apr 5;153(4). doi: 10.1085/jgp.202012633.
10
The Beta3 Adrenergic Receptor in Healthy and Pathological Cardiovascular Tissues.健康与病态心血管组织中的β3 肾上腺素能受体。
Cells. 2020 Dec 2;9(12):2584. doi: 10.3390/cells9122584.